Comparative Preclinical Evaluation of the Safety, Antifungal Activity, and Pharmacokinetics of Sertaconazole Products for External Use

Comparative Preclinical Evaluation of the Safety, Antifungal Activity, and Pharmacokinetics of Sertaconazole Products for External Use

SCIENTIFIC RELEVANCE. The high prevalence of fungal skin infections motivates expanding the range of sertaconazole products for external use.AIM. The study was a preclinical comparison of the safety, antifungal activity, and pharmacokinetics of Sertaverin® 2% medicated shampoo (VERTEX JSC, Russia) w...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. M. Kosman, M. V. Karlina, V. A. Vavilova, K. E. Borovkova, K. L. Kryshen, N. V. Marchenko, S. A. Kopatko, I. V. Sychkova, D. R. Kargopoltseva, M. N. Makarova, V. G. Makarov
Format:	Article
Language:	Russian
Published:	Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2024-04-01
Series:	Безопасность и риск фармакотерапии
Subjects:	sertaconazole shampoo solution topical application pharmacokinetics preclinical studies safety study rats antifungal activity
Online Access:	https://www.risksafety.ru/jour/article/view/358
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Documentary support for preclinical studies <i>in vivo</i> in accordance with the principles of Good Laboratory Practice
by: S. V. Khodko, et al.
Published: (2025-07-01)

Summary of Clinical Laboratory Studies Performed During Preclinical Safety Evaluation of Medicinal Products (Part II: Biochemical and Pathomorphological Studies)
by: A. V. Sorokina, et al.
Published: (2019-12-01)

Dose Selection in Preclinical Studies: Cross-Species Dose Conversion
by: E. V. Shekunova, et al.
Published: (2020-02-01)

Pharmacokinetic Interactions of Phenosanic Acid with Valproic Acid and Carbamazepine in Dogs
by: M. V. Karlina, et al.
Published: (2022-12-01)

Approaches to quality control, preclinical and clinical studies of live recombinant viral vector vaccines
by: L. M. Khantimirova, et al.
Published: (2021-12-01)

Preclinical Evaluation of a New Anti-COVID-19 Intravenous Immunoglobulin
by: A. M. Nikolaeva, et al.
Published: (2023-02-01)

Interpretation of toxicological research data in establishing the no observed adverse effect level (NOAEL) for medicinal products
by: K. L. Kryshen, et al.
Published: (2025-07-01)

Immunohistochemistry for assessing toxicity and mechanism of action of anticancer drugs during preclinical trials. From theory to practice
by: M. A. Dodokhova, et al.
Published: (2024-09-01)

Pharmacokinetics of Olivamide after Bolus Administration in Rats and Rabbits (a Pilot Study)
by: Yu. A. Portnoy, et al.
Published: (2020-05-01)

Biomedical cell product model for preclinical studies carried out on a large laboratory animal
by: M. N. Egorikhina, et al.
Published: (2020-04-01)

Determination of the Critical Phases of the Experimental Research Using Laboratory Animals: Risk Analysis
by: S. V. Khodko, et al.
Published: (2021-10-01)

PRECLINICAL AND CLINICAL ASPECTS OF THE DEVELOPMENT OF BIOMEDICAL CELL PRODUCTS
by: A. V. Tikhomirova, et al.
Published: (2018-03-01)

Food-derived extracellular vesicles for treatment of osteoporosis: a systematic review and meta-analysis of preclinical animal studies
by: Hongchen Shi, et al.
Published: (2025-08-01)

EXPERT EVALUATION OF PRECLINICAL STUDIES OF PRIMARY AND SECONDARY PHARMACODYNAMICS OF MEDICINES
by: G. N. Engalycheva, et al.
Published: (2018-12-01)

Effectiveness assessment of sulfur-containing amino acids in rats with experimental “alcohol withdrawal syndrome” with modified zoosocial interaction methods
by: V. I. Petrov, et al.
Published: (2024-05-01)

Methods of creation of bladder cancer models and their application in preclinical studies (literature review)
by: I. A. Kamaeva, et al.
Published: (2022-05-01)

Curcumin as a therapeutic agent in liver cancer: a systematic review of preclinical models and mechanisms
by: Ke Ma, et al.
Published: (2025-07-01)

The possibilities of immunohistochemistry for assessing the pathogenetic mechanisms of action of compounds with a suspected antitumor effect. Part I. General indicators of the process activity
by: M. A. Akimenko, et al.
Published: (2024-01-01)

The evolution of antifungal therapy: Traditional agents, current challenges and future perspectives
by: Cássia Milena de Souza, et al.
Published: (2025-01-01)

Comparative effects of moderate and high-intensity training on immune activation in myocarditis: a review of preclinical and clinical evidence
by: Bartolo Ferraro, et al.
Published: (2025-08-01)

Emodin, a rising star in the treatment of glycolipid metabolism disorders: a preclinical systematic review and meta-analysis
by: Yang Xiao, et al.
Published: (2025-05-01)

Comparative efficacy of transdermal forms for alopecia therapy
by: U. V. Nogaeva, et al.
Published: (2021-12-01)

Human papillomavirus vaccines: organisation and experience of preclinical studies
by: A. S. Korovkin, et al.
Published: (2024-10-01)

Safety Pharmacology Study of Medicines Used for Febrile Syndrome Management in Children
by: K. L. Kryshen, et al.
Published: (2020-09-01)

Evaluation of the antitumor activity of 2-[3-(2-chloroethyl)-3-nitrosoureido]-1,3-propanediol (chlonisol) in C57BL/6 mice with intracranially transplanted B16 melanoma
by: I. G. Murazov, et al.
Published: (2021-09-01)

Study of the General Toxic Properties of the Vaccine CoviVac in Immature Rats
by: A. A. Siniugina, et al.
Published: (2025-03-01)

Intracavitary Instillation of Antifungal Medication
by: Kun Zhang, et al.
Published: (2025-04-01)

Design of preclinical studies of biomedical cell products: characteristics, key principles and requirements
by: E. V. Melnikova, et al.
Published: (2018-02-01)

Structure of Pathogens Causing Invasive Mycoses and the Development of Their Resistance to Antifungal Drugs
by: A. V. Avtonomova, et al.
Published: (2025-04-01)

Study of Ridostin Pro and Poly(I:C) as adjuvants that enhance the immunogenicity of an antitumor vaccine
by: A. V. Ponomarev, et al.
Published: (2024-07-01)

Effect of Cu-chitosan Composite Based Seed Coating on Seed Quality Enhancement and Antifungal Activity
by: B. M. Sangeetha, et al.
Published: (2025-05-01)

Evaluation of the Efficiency of a Soft Dosage Form for the Treatment of Osteoarthritis: Influence on the Level of Pro-inflammatory Cytokines
by: U. V. Nogaeva, et al.
Published: (2023-02-01)

Validation of Enzyme Immunoassay for Preclinical Pharmacokinetic Trials of Rituximab
by: V. V Pisarev, et al.
Published: (2019-06-01)

Preclinical safety studies of medicines in the Eurasian economic union
by: G. N. Engalycheva, et al.
Published: (2025-05-01)

Gene therapy of neurodegenerative diseases: achievements, developments, and clinical implementation challenges
by: E. V. Melnikova, et al.
Published: (2023-06-01)

Exploring the Potential of Cleansing Hydrogel and Shampoo with Whey as a Contemporary Approach to Sustainability
by: Maja Bjelošević Žiberna, et al.
Published: (2025-05-01)

Scalp Microbiome Dynamics Can Contribute to the Clinical Effect of a Novel Antiseborrheic Dermatitis Shampoo Containing Patented Antifungal Actives: A Randomized Controlled Study
by: Martine Maître, et al.
Published: (2025-06-01)

Next-generation antifungal drugs: Mechanisms, efficacy, and clinical prospects
by: Xueni Lu, et al.
Published: (2025-08-01)

SPECIFIC ASPECTS OF BENEFIT-RISK EVALUATION OF HERBAL MEDICINAL PRODUCTS: ANALYSIS OF REGISTRATION DOSSIERS
by: N. G. Olenina, et al.
Published: (2018-06-01)

Novel insights from meta-analysis: the efficacy of ginsenosides in non-alcoholic fatty liver disease
by: Liyuan Hao, et al.
Published: (2025-05-01)